ARCHIMED and La Caisse to acquire a majority stake in Stago Group for €1.1bn.

ARCHIMED, a private equity healthcare specialist, agreed to acquire a majority stake in Stago Group, a company specializing in diagnostics and a specialist in hemostasis, for €1.1bn. La Caisse would invest alongside ARCHIMED as a minority investor. This transaction would provide Stago with the necessary resources to accelerate its growth strategy, while strengthening its technological and scientific leadership. The project would build on the recognized expertise of Stago's teams and be in line with their strategic vision, maintaining their commitments in terms of quality, customer satisfaction, and diagnostic reliability in the service of patients.